That the House of Representatives— (1) recognizes the value of pre-exposure prophylaxis (PrEP) as an effective prevention tool in combating human immunodeficiency virus (HIV); (2) supports the research, education, and usage of the current PrEP and encourages the medical community, both private and public, to continue working on creating new PrEP medications to reduce the spread of HIV; (3) calls on Congress to increase funding to existing programs that are working to educate the public and healthcare professionals about PrEP, how it works, how and when to prescribe these medicines, and how individuals who qualify to take the regimen can obtain it; and (4) calls on the Secretary of Health and Human Services to— (A) conduct a departmentwide review on the outreach efforts of all HIV prevention programs in agencies such as the Health Resources and Service Administration, the Centers for Disease Control and Prevention, the Substance Abuse and Mental Health Services Administration, and others to ensure that they are conducting effective outreach, especially to communities of color, gay and bisexual men, and transgender people; and (B) conduct a study on the solutions to the barriers individuals face in accessing PrEP medication and its associated services, such as HIV and other STI screening, especially among communities of color, gay and bisexual men, and transgender people.